Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous conditioned plasma injection for acute hamstring injury
NL-OMON23513Active, not recruiting
- Sponsor
- Arthrex
- Start
- Feb 2011
- Countries
- 1
01
Overview
Randomised, double-blind trial in Hamstring Injury comparing ACP injection + exercise therapy with Placebo injection + exercise therapy (2 arms). Primary endpoint: Time to return to full sports activity. Started Feb 2011; status: active, not recruiting.
02
Drugs
autologous conditioned plasma
03
Conditions
Hamstring Injury
Beyond the preview
Go deeper on NL-OMON23513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23513.